Dr. Birch holds a DPhil in Fungal Pathology from the University of Oxford. Her career includes a role as VP of Business Development at Neumora and experience as a venture capital investor at Biomatics Capital. She specializes in translating complex scientific concepts into compelling value propositions for partnerships and investment. She is a likely speaker at conferences such as BIO, Bio Europe, and Neuroscience (SfN) on topics of biotech business development, neurodegenerative therapies, and investment strategy.